SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Berger A, Dukes E, Martin S, Edelsberg J, Oster G. Characteristics and healthcare costs of patients with fibromyalgia syndrome. Int J Clin Pract 2007; 61: 1498508.
  • 2
    Thompson JM, Luedtke CA, Oh TH, Shah ND, Long KH, King S, et al. Direct medical costs in patients with fibromyalgia: cost of illness and impact of a brief multidisciplinary treatment program. Am J Phys Med Rehabil 2011; 90: 406.
  • 3
    Sanchez RJ, Uribe C, Li H, Alvir J, Deminski M, Chandran A, et al. Longitudinal evaluation of health care utilization and costs during the first three years after a new diagnosis of fibromyalgia. Curr Med Res Opin 2011; 27: 66371.
  • 4
    Berger A, Sadosky A, Dukes EM, Edelsberg J, Zlateva G, Oster G. Patterns of healthcare utilization and cost in patients with newly diagnosed fibromyalgia. Am J Manag Care 2010; 16 Suppl: S12637.
  • 5
    Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the Multicenter Criteria Committee. Arthritis Rheum 1990; 33: 16072.
  • 6
    Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995; 38: 1928.
  • 7
    White KP, Speechley M, Harth M, Ostbye T. The London Fibromyalgia Epidemiology Study: the prevalence of fibromyalgia syndrome in London, Ontario. J Rheumatol 1999; 26: 15706.
  • 8
    Branco JC, Bannwarth B, Failde I, Abello Carbonell J, Blotman F, Spaeth M, et al. Prevalence of fibromyalgia: a survey in five European countries. Semin Arthritis Rheum 2010; 39: 44853.
  • 9
    Hauser W, Schmutzer G, Glaesmer H, Brahler E. Prevalence and predictors of pain in several body regions: results of a representative German population survey. Schmerz 2009; 23: 46170. In German.
  • 10
    Wolfe F, Clauw DJ, FitzCharles MA, Goldenberg DL, Katz RS, Mease P, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken) 2010; 62: 60010.
  • 11
    Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Hauser W, Katz RS, et al. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR preliminary diagnostic criteria for fibromyalgia. J Rheumatol 2011; 38: 111322.
  • 12
    Melton LJ III. History of the Rochester Epidemiology Project. Mayo Clin Proc 1996; 71: 26674.
  • 13
    St. Sauver JL, Grossardt BR, Yawn BP, Melton LJ III, Rocca WA. Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester Epidemiology Project. Am J Epidemiol 2011; 173: 105968.
  • 14
    Bergstralh EJ, Offord KP, Chu CP, Beard CM, O'Fallon WM, Melton LJ III. Technical report series no. 49. Calculating incidence, prevalence and mortality rates for Olmsted County, Minnesota: an update. Rochester (MN): Division of Biomedical Statistics and Informatics, Mayo Clinic; 1992.
  • 15
    Neumann L, Buskila D. Epidemiology of fibromyalgia. Curr Pain Headache Rep 2003; 7: 3628.
  • 16
    Leresche L. Defining gender disparities in pain management. Clin Orthop Relat Res 2011; 469: 18717.